Polomar Health (PMHS) Insider Buys 141,028 Shares — Form 4 Filed
Rhea-AI Filing Summary
Polomar Health Services (PMHS) insider buying disclosed on Form 4. Terrence M. Tierney, President and Director, reported three open-market purchases: 125,000 shares on 06/27/2025, 8,333 shares on 07/15/2025 and 7,695 shares on 08/15/2025, bringing his beneficial ownership to 141,028 shares. Reported aggregate cash amounts are shown for each lot on the form. The Form 4 is signed by the reporting person.
Positive
- Insider purchases totaling 141,028 shares across three transactions (06/27/2025, 07/15/2025, 08/15/2025)
- Reporting person is both President and Director, indicating senior management participation in purchases
- Form 4 appears properly executed and signed by the reporting person
Negative
- None.
Insights
TL;DR: Company insider made a sequence of open-market purchases increasing ownership to 141,028 shares, a potentially constructive signal.
Tierney, who serves as both President and a director, filed three acquisitions over summer 2025 totaling 141,028 shares. The transactions are reported as direct ownership increases and were reported on a timely Form 4 with a manual signature. From a trading-activity perspective, clustered insider purchases by an executive can signal confidence in the company, though the filing does not disclose the issuer's outstanding shares or stake percentage, so absolute materiality cannot be assessed from this form alone.
TL;DR: Insider purchases follow required disclosure procedures; filings show direct ownership increases but lack context on stake size.
The Form 4 documents three non-derivative acquisitions by a reporting officer/director and identifies the transactions as direct beneficial ownership. The form appears properly executed and signed. The filing does not include information on whether purchases were pursuant to a Rule 10b5-1 plan or any trading restrictions, and it provides no ownership percentage or outstanding share count, which limits governance conclusions about control or dilution.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,695 | $2,693.00 | $20.72M |
| Grant/Award | Common Stock | 8,333 | $2,917.00 | $24.31M |
| Grant/Award | Common Stock | 125,000 | $43,750.00 | $5.47B |